The Connect® Registries are observational studies of Myeloid diseases (Connect® Myeloid) and Multiple Myeloma (Connect® MM). Unlike clinical trials, registries do not require or provide any specific medications or healthcare services but leave those decisions to the treating doctors and their patients.
The data collected as part of the Connect® Registries have provided insight into treatment options, quality of life, and standard of care practices. This information is used to advance knowledge about these hematologic diseases.
The Connect® Registry Team would like to thank all the patients and their caregivers who have contributed so far to the Connect® Registries. Because of you, we have been able to collect information on Myeloid diseases and Multiple Myeloma (MM).